SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Ocean Bio-Chem, Inc. (Nasdaq – OBCI)

BALA CYNWYD – June 22, 2022 /Globe Newswire/ – Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Ocean Bio-Chem, Inc. (“Ocean Bio-Chem” or the “Company”) (Nasdaq – OBCI) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the Company’s agreement to be acquired by OneWater Marine Inc. (“OneWater”) (Nasdaq – ONEW). Under the terms of the Transaction, OneWater will acquire all of the outstanding shares of Ocean Bio-Chem common stock for $13.08 per share in cash.

The investigation concerns whether the Ocean Bio-Chem Board breached its fiduciary duties to shareholders by failing to conduct a fair process, and whether the deal is fair to Ocean Bio-Chem shareholders.

If you own shares of Ocean Bio-Chem stock and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire, or Marc L. Ackerman, Esquire at Brodsky & Smith, Two Bala Plaza, Suite 805, Bala Cynwyd, PA 19004, or call toll free 855-576-4847.

Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.